History of Metabolic Syndrome

The risk factors associated with diabetes were observed as early on as the 1920s, but the term “metabolic syndrome” was only coined in the 1950s and then became commonly used in the 1970s.

In 1947, the French physician Jean Vague noticed that upper body obesity seemed to be associated with an increased risk for the conditions atherosclerosis, diabetes, kidney stones and gout. Avogaro, Crepaldi and colleagues then reported how six obese patients demonstrated improvements in their  diabetes, high blood cholesterol and high triglycerides when they followed a low-calorie and low-carbohydrate diet.

The term “metabolic syndrome” was used in 1977 by Herman Haller who was studying the risk factors associated with atherosclerosis. He used the term in reference to the associations between obesity, diabetes mellitus, high blood lipids, a high uric acid level (predisposes to gout) and fatty liver disease (hepatic steatosis) and how the combined presence of these factors increase the risk of atherosclerosis developing. In the same year, Singer used the term to describe the associations between hyperlipoprotenemia and obesity, gout, diabetes mellitus, and hypertension.

The next year, Gerald Phillips introduced the concept that a combination of risk factors exist for myocardial infarction that not only predispose to heart disease, but are also associated with an increased risk for obesity and other clinical states. He described the presence of these risk factors as a “constellation of abnormalities” and they included glucose intolerance, hyperinsulinemia and a high level of triglycerides, glucose, cholesterol and insulin. Phillips hypothesized that one underlying factor could be linked to the combined presence of these risk factors that if identified, could be researched to help prevent cardiovascular disease. He suggested that this common factor could involve the sex hormones.  

In 1988, Gerald Reaven hypothesized that insulin resistance could be the underlying factor linking this constellation of abnormalities, which he went on to name “syndrome X.”

Sources

  1. http://www.nhs.uk/conditions/metabolic-syndrome/Pages/Introduction.aspx
  2. http://www.diabetes.co.uk/diabetes-and-metabolic-syndrome.html
  3. http://www.bbc.co.uk/radio4/science/casenotes_20080122.shtml
  4. https://idf.org/

Further Reading

Last Updated: Jul 3, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 03). History of Metabolic Syndrome. News-Medical. Retrieved on November 17, 2024 from https://www.news-medical.net/health/History-of-Metabolic-Syndrome.aspx.

  • MLA

    Mandal, Ananya. "History of Metabolic Syndrome". News-Medical. 17 November 2024. <https://www.news-medical.net/health/History-of-Metabolic-Syndrome.aspx>.

  • Chicago

    Mandal, Ananya. "History of Metabolic Syndrome". News-Medical. https://www.news-medical.net/health/History-of-Metabolic-Syndrome.aspx. (accessed November 17, 2024).

  • Harvard

    Mandal, Ananya. 2023. History of Metabolic Syndrome. News-Medical, viewed 17 November 2024, https://www.news-medical.net/health/History-of-Metabolic-Syndrome.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GLP-1 drugs protect brain health by improving neurovascular function and reducing inflammation